ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ketorolac Tromethamine Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39K10320
Home | Market Reports | Health| Health Conditions| Pain Management
Global and United States Ketorolac Tromethamine Market Report Forecast 2022 2028
BUY CHAPTERS

Global Ketorolac Tromethamine Market Research Report 2025

Code: QYRE-Auto-39K10320
Report
September 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Omeros Corporation
Egalet US Inc.
Allergan plc
Dr. Reddy’s Laboratories
TEVA
Mylan NV
Apotex
Sandoz Inc
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma

Ketorolac Tromethamine Market Size

The global market for Ketorolac Tromethamine was valued at US$ 258 million in the year 2024 and is projected to reach a revised size of US$ 364 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Ketorolac Tromethamine Market

Ketorolac Tromethamine Market

Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the short-term (up to 5 days in adults) management of moderately severe acute pain that requires analgesia at the opioid level.
Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug (NSAID) used for the short-term treatment of moderate to severe pain. It works by reducing inflammation and pain in the body.There is a rising prevalence of pain-related conditions such as postoperative pain, musculoskeletal pain, and migraines, which drives the demand for pain medications like ketorolac tromethamine. The aging population is more prone to chronic pain, leading to a greater need for effective pain management solutions. Ketorolac tromethamine is commonly used in geriatric patients due to its potent analgesic properties. In recent years, there has been a growing concern about the opioid epidemic and the need for non-opioid pain management options. Ketorolac tromethamine, as an NSAID, offers an alternative pain relief option with a lower risk of addiction or dependence. The global increase in surgical procedures, including both elective and emergency surgeries, drives the demand for postoperative pain management medications like ketorolac tromethamine. The development of innovative drug delivery systems, such as transdermal patches and intranasal formulations, has improved the convenience and effectiveness of ketorolac tromethamine administration, making it a preferred choice for patients. Governments worldwide are implementing regulations to promote the use of non-opioid pain medications and improve access to pain management options. These regulations create a supportive environment for the growth of the ketorolac tromethamine market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ketorolac Tromethamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ketorolac Tromethamine.
The Ketorolac Tromethamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ketorolac Tromethamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac Tromethamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ketorolac Tromethamine Market Report

Report Metric Details
Report Name Ketorolac Tromethamine Market
Accounted market size in year US$ 258 million
Forecasted market size in 2031 US$ 364 million
CAGR 5.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Omeros Corporation, Egalet US Inc., Allergan, Dr. Reddy’s Laboratories, Teva, Mylan, Apotex, Sandoz, Amphastar Pharmaceuticals, Gland Pharma Limited, Akorn, Sun Pharmaceutical, Sagent Pharmaceuticals, Aurobindo Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ketorolac Tromethamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ketorolac Tromethamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Ketorolac Tromethamine Market growing?

Ans: The Ketorolac Tromethamine Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Ketorolac Tromethamine Market size in 2031?

Ans: The Ketorolac Tromethamine Market size in 2031 will be US$ 364 million.

Who are the main players in the Ketorolac Tromethamine Market report?

Ans: The main players in the Ketorolac Tromethamine Market are Pfizer, Omeros Corporation, Egalet US Inc., Allergan, Dr. Reddy’s Laboratories, Teva, Mylan, Apotex, Sandoz, Amphastar Pharmaceuticals, Gland Pharma Limited, Akorn, Sun Pharmaceutical, Sagent Pharmaceuticals, Aurobindo Pharma

What are the Application segmentation covered in the Ketorolac Tromethamine Market report?

Ans: The Applications covered in the Ketorolac Tromethamine Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Ketorolac Tromethamine Market report?

Ans: The Types covered in the Ketorolac Tromethamine Market report are Injection, Ophthalmic, Nasal, Oral tablet

Recommended Reports

Pain Management

NSAIDs & Analgesics

Osteoarthritis & Pain

1 Ketorolac Tromethamine Market Overview
1.1 Product Definition
1.2 Ketorolac Tromethamine by Type
1.2.1 Global Ketorolac Tromethamine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection
1.2.3 Ophthalmic
1.2.4 Nasal
1.2.5 Oral tablet
1.3 Ketorolac Tromethamine by Application
1.3.1 Global Ketorolac Tromethamine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Ketorolac Tromethamine Market Size Estimates and Forecasts
1.4.1 Global Ketorolac Tromethamine Revenue 2020-2031
1.4.2 Global Ketorolac Tromethamine Sales 2020-2031
1.4.3 Global Ketorolac Tromethamine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ketorolac Tromethamine Market Competition by Manufacturers
2.1 Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ketorolac Tromethamine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ketorolac Tromethamine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ketorolac Tromethamine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ketorolac Tromethamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ketorolac Tromethamine, Product Type & Application
2.7 Global Key Manufacturers of Ketorolac Tromethamine, Date of Enter into This Industry
2.8 Global Ketorolac Tromethamine Market Competitive Situation and Trends
2.8.1 Global Ketorolac Tromethamine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ketorolac Tromethamine Players Market Share by Revenue
2.8.3 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ketorolac Tromethamine Market Scenario by Region
3.1 Global Ketorolac Tromethamine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ketorolac Tromethamine Sales by Region: 2020-2031
3.2.1 Global Ketorolac Tromethamine Sales by Region: 2020-2025
3.2.2 Global Ketorolac Tromethamine Sales by Region: 2026-2031
3.3 Global Ketorolac Tromethamine Revenue by Region: 2020-2031
3.3.1 Global Ketorolac Tromethamine Revenue by Region: 2020-2025
3.3.2 Global Ketorolac Tromethamine Revenue by Region: 2026-2031
3.4 North America Ketorolac Tromethamine Market Facts & Figures by Country
3.4.1 North America Ketorolac Tromethamine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ketorolac Tromethamine Sales by Country (2020-2031)
3.4.3 North America Ketorolac Tromethamine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ketorolac Tromethamine Market Facts & Figures by Country
3.5.1 Europe Ketorolac Tromethamine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ketorolac Tromethamine Sales by Country (2020-2031)
3.5.3 Europe Ketorolac Tromethamine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Region
3.6.1 Asia Pacific Ketorolac Tromethamine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ketorolac Tromethamine Sales by Region (2020-2031)
3.6.3 Asia Pacific Ketorolac Tromethamine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ketorolac Tromethamine Market Facts & Figures by Country
3.7.1 Latin America Ketorolac Tromethamine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ketorolac Tromethamine Sales by Country (2020-2031)
3.7.3 Latin America Ketorolac Tromethamine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Ketorolac Tromethamine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ketorolac Tromethamine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ketorolac Tromethamine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Ketorolac Tromethamine Sales by Type (2020-2031)
4.1.1 Global Ketorolac Tromethamine Sales by Type (2020-2025)
4.1.2 Global Ketorolac Tromethamine Sales by Type (2026-2031)
4.1.3 Global Ketorolac Tromethamine Sales Market Share by Type (2020-2031)
4.2 Global Ketorolac Tromethamine Revenue by Type (2020-2031)
4.2.1 Global Ketorolac Tromethamine Revenue by Type (2020-2025)
4.2.2 Global Ketorolac Tromethamine Revenue by Type (2026-2031)
4.2.3 Global Ketorolac Tromethamine Revenue Market Share by Type (2020-2031)
4.3 Global Ketorolac Tromethamine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ketorolac Tromethamine Sales by Application (2020-2031)
5.1.1 Global Ketorolac Tromethamine Sales by Application (2020-2025)
5.1.2 Global Ketorolac Tromethamine Sales by Application (2026-2031)
5.1.3 Global Ketorolac Tromethamine Sales Market Share by Application (2020-2031)
5.2 Global Ketorolac Tromethamine Revenue by Application (2020-2031)
5.2.1 Global Ketorolac Tromethamine Revenue by Application (2020-2025)
5.2.2 Global Ketorolac Tromethamine Revenue by Application (2026-2031)
5.2.3 Global Ketorolac Tromethamine Revenue Market Share by Application (2020-2031)
5.3 Global Ketorolac Tromethamine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Ketorolac Tromethamine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Omeros Corporation
6.2.1 Omeros Corporation Company Information
6.2.2 Omeros Corporation Description and Business Overview
6.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Omeros Corporation Ketorolac Tromethamine Product Portfolio
6.2.5 Omeros Corporation Recent Developments/Updates
6.3 Egalet US Inc.
6.3.1 Egalet US Inc. Company Information
6.3.2 Egalet US Inc. Description and Business Overview
6.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Egalet US Inc. Ketorolac Tromethamine Product Portfolio
6.3.5 Egalet US Inc. Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Company Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergan Ketorolac Tromethamine Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Dr. Reddy’s Laboratories
6.5.1 Dr. Reddy’s Laboratories Company Information
6.5.2 Dr. Reddy’s Laboratories Description and Business Overview
6.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio
6.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Ketorolac Tromethamine Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Mylan
6.7.1 Mylan Company Information
6.7.2 Mylan Description and Business Overview
6.7.3 Mylan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mylan Ketorolac Tromethamine Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Apotex
6.8.1 Apotex Company Information
6.8.2 Apotex Description and Business Overview
6.8.3 Apotex Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Apotex Ketorolac Tromethamine Product Portfolio
6.8.5 Apotex Recent Developments/Updates
6.9 Sandoz
6.9.1 Sandoz Company Information
6.9.2 Sandoz Description and Business Overview
6.9.3 Sandoz Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sandoz Ketorolac Tromethamine Product Portfolio
6.9.5 Sandoz Recent Developments/Updates
6.10 Amphastar Pharmaceuticals
6.10.1 Amphastar Pharmaceuticals Company Information
6.10.2 Amphastar Pharmaceuticals Description and Business Overview
6.10.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio
6.10.5 Amphastar Pharmaceuticals Recent Developments/Updates
6.11 Gland Pharma Limited
6.11.1 Gland Pharma Limited Company Information
6.11.2 Gland Pharma Limited Description and Business Overview
6.11.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Gland Pharma Limited Ketorolac Tromethamine Product Portfolio
6.11.5 Gland Pharma Limited Recent Developments/Updates
6.12 Akorn
6.12.1 Akorn Company Information
6.12.2 Akorn Description and Business Overview
6.12.3 Akorn Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Akorn Ketorolac Tromethamine Product Portfolio
6.12.5 Akorn Recent Developments/Updates
6.13 Sun Pharmaceutical
6.13.1 Sun Pharmaceutical Company Information
6.13.2 Sun Pharmaceutical Description and Business Overview
6.13.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio
6.13.5 Sun Pharmaceutical Recent Developments/Updates
6.14 Sagent Pharmaceuticals
6.14.1 Sagent Pharmaceuticals Company Information
6.14.2 Sagent Pharmaceuticals Description and Business Overview
6.14.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio
6.14.5 Sagent Pharmaceuticals Recent Developments/Updates
6.15 Aurobindo Pharma
6.15.1 Aurobindo Pharma Company Information
6.15.2 Aurobindo Pharma Description and Business Overview
6.15.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Aurobindo Pharma Ketorolac Tromethamine Product Portfolio
6.15.5 Aurobindo Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ketorolac Tromethamine Industry Chain Analysis
7.2 Ketorolac Tromethamine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ketorolac Tromethamine Production Mode & Process Analysis
7.4 Ketorolac Tromethamine Sales and Marketing
7.4.1 Ketorolac Tromethamine Sales Channels
7.4.2 Ketorolac Tromethamine Distributors
7.5 Ketorolac Tromethamine Customer Analysis
8 Ketorolac Tromethamine Market Dynamics
8.1 Ketorolac Tromethamine Industry Trends
8.2 Ketorolac Tromethamine Market Drivers
8.3 Ketorolac Tromethamine Market Challenges
8.4 Ketorolac Tromethamine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Omeros Corporation
Egalet US Inc.
Allergan plc
Dr. Reddy’s Laboratories
TEVA
Mylan NV
Apotex
Sandoz Inc
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma
List of Tables
 Table 1. Global Ketorolac Tromethamine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ketorolac Tromethamine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ketorolac Tromethamine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ketorolac Tromethamine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ketorolac Tromethamine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ketorolac Tromethamine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ketorolac Tromethamine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ketorolac Tromethamine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ketorolac Tromethamine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ketorolac Tromethamine, Product Type & Application
 Table 12. Global Key Manufacturers of Ketorolac Tromethamine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Tromethamine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ketorolac Tromethamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ketorolac Tromethamine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ketorolac Tromethamine Sales Market Share by Region (2020-2025)
 Table 19. Global Ketorolac Tromethamine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ketorolac Tromethamine Sales Market Share by Region (2026-2031)
 Table 21. Global Ketorolac Tromethamine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ketorolac Tromethamine Revenue Market Share by Region (2020-2025)
 Table 23. Global Ketorolac Tromethamine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ketorolac Tromethamine Revenue Market Share by Region (2026-2031)
 Table 25. North America Ketorolac Tromethamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ketorolac Tromethamine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ketorolac Tromethamine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ketorolac Tromethamine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ketorolac Tromethamine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ketorolac Tromethamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ketorolac Tromethamine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ketorolac Tromethamine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ketorolac Tromethamine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ketorolac Tromethamine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ketorolac Tromethamine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ketorolac Tromethamine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ketorolac Tromethamine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ketorolac Tromethamine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ketorolac Tromethamine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ketorolac Tromethamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ketorolac Tromethamine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ketorolac Tromethamine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ketorolac Tromethamine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ketorolac Tromethamine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ketorolac Tromethamine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ketorolac Tromethamine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ketorolac Tromethamine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ketorolac Tromethamine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ketorolac Tromethamine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ketorolac Tromethamine Sales (K Units) by Type (2020-2025)
 Table 51. Global Ketorolac Tromethamine Sales (K Units) by Type (2026-2031)
 Table 52. Global Ketorolac Tromethamine Sales Market Share by Type (2020-2025)
 Table 53. Global Ketorolac Tromethamine Sales Market Share by Type (2026-2031)
 Table 54. Global Ketorolac Tromethamine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ketorolac Tromethamine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ketorolac Tromethamine Revenue Market Share by Type (2020-2025)
 Table 57. Global Ketorolac Tromethamine Revenue Market Share by Type (2026-2031)
 Table 58. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Ketorolac Tromethamine Sales (K Units) by Application (2020-2025)
 Table 61. Global Ketorolac Tromethamine Sales (K Units) by Application (2026-2031)
 Table 62. Global Ketorolac Tromethamine Sales Market Share by Application (2020-2025)
 Table 63. Global Ketorolac Tromethamine Sales Market Share by Application (2026-2031)
 Table 64. Global Ketorolac Tromethamine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ketorolac Tromethamine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ketorolac Tromethamine Revenue Market Share by Application (2020-2025)
 Table 67. Global Ketorolac Tromethamine Revenue Market Share by Application (2026-2031)
 Table 68. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Ketorolac Tromethamine Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Omeros Corporation Company Information
 Table 76. Omeros Corporation Description and Business Overview
 Table 77. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Omeros Corporation Ketorolac Tromethamine Product
 Table 79. Omeros Corporation Recent Developments/Updates
 Table 80. Egalet US Inc. Company Information
 Table 81. Egalet US Inc. Description and Business Overview
 Table 82. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Egalet US Inc. Ketorolac Tromethamine Product
 Table 84. Egalet US Inc. Recent Developments/Updates
 Table 85. Allergan Company Information
 Table 86. Allergan Description and Business Overview
 Table 87. Allergan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Allergan Ketorolac Tromethamine Product
 Table 89. Allergan Recent Developments/Updates
 Table 90. Dr. Reddy’s Laboratories Company Information
 Table 91. Dr. Reddy’s Laboratories Description and Business Overview
 Table 92. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product
 Table 94. Dr. Reddy’s Laboratories Recent Developments/Updates
 Table 95. Teva Company Information
 Table 96. Teva Description and Business Overview
 Table 97. Teva Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Ketorolac Tromethamine Product
 Table 99. Teva Recent Developments/Updates
 Table 100. Mylan Company Information
 Table 101. Mylan Description and Business Overview
 Table 102. Mylan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Mylan Ketorolac Tromethamine Product
 Table 104. Mylan Recent Developments/Updates
 Table 105. Apotex Company Information
 Table 106. Apotex Description and Business Overview
 Table 107. Apotex Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Apotex Ketorolac Tromethamine Product
 Table 109. Apotex Recent Developments/Updates
 Table 110. Sandoz Company Information
 Table 111. Sandoz Description and Business Overview
 Table 112. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Sandoz Ketorolac Tromethamine Product
 Table 114. Sandoz Recent Developments/Updates
 Table 115. Amphastar Pharmaceuticals Company Information
 Table 116. Amphastar Pharmaceuticals Description and Business Overview
 Table 117. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Amphastar Pharmaceuticals Ketorolac Tromethamine Product
 Table 119. Amphastar Pharmaceuticals Recent Developments/Updates
 Table 120. Gland Pharma Limited Company Information
 Table 121. Gland Pharma Limited Description and Business Overview
 Table 122. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Gland Pharma Limited Ketorolac Tromethamine Product
 Table 124. Gland Pharma Limited Recent Developments/Updates
 Table 125. Akorn Company Information
 Table 126. Akorn Description and Business Overview
 Table 127. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Akorn Ketorolac Tromethamine Product
 Table 129. Akorn Recent Developments/Updates
 Table 130. Sun Pharmaceutical Company Information
 Table 131. Sun Pharmaceutical Description and Business Overview
 Table 132. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Sun Pharmaceutical Ketorolac Tromethamine Product
 Table 134. Sun Pharmaceutical Recent Developments/Updates
 Table 135. Sagent Pharmaceuticals Company Information
 Table 136. Sagent Pharmaceuticals Description and Business Overview
 Table 137. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Sagent Pharmaceuticals Ketorolac Tromethamine Product
 Table 139. Sagent Pharmaceuticals Recent Developments/Updates
 Table 140. Aurobindo Pharma Company Information
 Table 141. Aurobindo Pharma Description and Business Overview
 Table 142. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Aurobindo Pharma Ketorolac Tromethamine Product
 Table 144. Aurobindo Pharma Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Ketorolac Tromethamine Distributors List
 Table 148. Ketorolac Tromethamine Customers List
 Table 149. Ketorolac Tromethamine Market Trends
 Table 150. Ketorolac Tromethamine Market Drivers
 Table 151. Ketorolac Tromethamine Market Challenges
 Table 152. Ketorolac Tromethamine Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ketorolac Tromethamine
 Figure 2. Global Ketorolac Tromethamine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ketorolac Tromethamine Market Share by Type: 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Ophthalmic Product Picture
 Figure 6. Nasal Product Picture
 Figure 7. Oral tablet Product Picture
 Figure 8. Global Ketorolac Tromethamine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Ketorolac Tromethamine Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Others
 Figure 13. Global Ketorolac Tromethamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Ketorolac Tromethamine Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Ketorolac Tromethamine Sales (2020-2031) & (K Units)
 Figure 16. Global Ketorolac Tromethamine Average Price (USD/Unit) & (2020-2031)
 Figure 17. Ketorolac Tromethamine Report Years Considered
 Figure 18. Ketorolac Tromethamine Sales Share by Manufacturers in 2024
 Figure 19. Global Ketorolac Tromethamine Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Ketorolac Tromethamine Players: Market Share by Revenue in Ketorolac Tromethamine in 2024
 Figure 21. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Ketorolac Tromethamine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Ketorolac Tromethamine Sales Market Share by Country (2020-2031)
 Figure 24. North America Ketorolac Tromethamine Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Ketorolac Tromethamine Sales Market Share by Country (2020-2031)
 Figure 28. Europe Ketorolac Tromethamine Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Ketorolac Tromethamine Revenue Market Share by Region (2020-2031)
 Figure 36. China Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Ketorolac Tromethamine Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Ketorolac Tromethamine Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Ketorolac Tromethamine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Ketorolac Tromethamine by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Ketorolac Tromethamine by Type (2020-2031)
 Figure 58. Global Ketorolac Tromethamine Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Ketorolac Tromethamine by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Ketorolac Tromethamine by Application (2020-2031)
 Figure 61. Global Ketorolac Tromethamine Price (USD/Unit) by Application (2020-2031)
 Figure 62. Ketorolac Tromethamine Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Ketorolac Market Research Report 2024
Global Ketorolac Tromethamine API Market Research Report 2024
Global Ketorolac Trometamol Market Research Report 2025
Global Ketorolac Injection Market Research Report 2024
Pharmaceutical Grade Ketorolac Tromethamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ketoprofen Market Insights Forecast to 2030
Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030
Global Ketoprofen Gel Market Research Report 2024
Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024
Paracetamol and Tramadol Hydrochloride Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Celecoxib Capsule Market Insights Forecast to 2030
Global Rofecoxib Market Insights Forecast to 2030
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Carprofen Market Research Report 2025
Global Celecoxib Market Insights Forecast to 2030
Global Meloxicam Drugs Market Research Report 2024
Global Dexketoprofen Trometamol Market Research Report 2025
Global Piroxicam Market Research Report 2024
Global Pets NSAIDs Market Research Report 2025
Global Lornoxicam Tablets Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions